Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
NASDAQ:COLL
Price:
23.6775
USD
-1.47%
Market Closed
Market Cap:
$767.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
E
|
Edel SE & Co KgaA
XMUN:EDL
|
DE |
|
F
|
Fanuc Corp
F:FUC
|
JP |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
C
|
CapitaLand Ascendas REIT
OTC:ACDSF
|
SG |
|
Majestic Corporation PLC
OTC:MCJCF
|
UK |
|
S
|
Sovereign Metals Ltd
F:SVM
|
AU |
Wall St Price Targets
COLL Price Forecast
Based on 10 analysts
Based on 10 analysts
+109% Upside
from
$23.6775
today
Collegium Pharmaceutical Inc (COLL)’s 12-month stock price forecast through October 2027 has a consensus target of $49.47, implying 109% upside. The forecast is based on price targets from 10 Wall Street analysts.
COLL Analyst Rating
Based on 8 analysts
Based on 8 analysts
Analysts rate COLL Strong buy, with 7 of 8 recommending Buy or Strong buy.
Collegium Pharmaceutical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is COLL's stock price target?
Price Target
49.47
USD
49.47
USD
According to Wall Street analysts, the average 1-year price target for COLL is 49.47 USD with a low forecast of 43.43 USD and a high forecast of 63 USD.
What is the Revenue forecast for Collegium Pharmaceutical Inc?
Projected CAGR
-3%
-3%
The compound annual growth rate for Revenue over the next 8 years is -3%.
What is the Gross Profit forecast for Collegium Pharmaceutical Inc?
Projected CAGR
13%
13%
The compound annual growth rate for Gross Profit over the next 5 years is 13%.
What is the Operating Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Operating Income over the next 5 years is 21%.
What is the Pre-Tax Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
56%
56%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 56%.
What is the Net Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
-1%
-1%
The compound annual growth rate for Net Income over the next 8 years is -1%.